A trail published mid 2020 has been higlighted by ingredient supplier BioEnergy Life Science, which markets its branded, patented D-ribose ingredient. The researchers, who are associated with the University of Kansas Health system, are looking at how a combination of d-ribose (BioEnergy Ribose®) and ubiquinol, could benefit patients with a particular kind of heart failure, known as heart failure with preserved ejection faction, called HFpEF for short.